SCHEDULE: Dimensional Fund Advisors Discloses 5% Stake in Elanco Animal Health
Beneficial Ownership Disclosure
Dimensional Fund Advisors LP has reported a 5.0% beneficial ownership stake in Elanco Animal Health Inc, holding over 25 million shares of common stock.
Summary
- Dimensional Fund Advisors LP (DFA) filed a Schedule 13G, indicating beneficial ownership of Elanco Animal Health Inc common stock.
- DFA beneficially owns an aggregate of 25,082,545 shares of Elanco Animal Health Inc, representing 5.0% of the class.
- DFA holds sole voting power over 24,595,193 shares and sole dispositive power over 25,082,545 shares.
- The shares are held by various investment companies, commingled funds, group trusts, and separate accounts for which DFA acts as an investment adviser or manager.
- DFA disclaims beneficial ownership of these securities, stating they are owned by the Funds.
- The acquisition and holding of these securities are in the ordinary course of business and not for the purpose of changing or influencing control of Elanco Animal Health Inc.
Sentiment
Score: 6
Explanation: The filing is neutral in tone, as it is a factual disclosure of ownership. The presence of a significant institutional investor holding a 5% stake can be seen as a minor positive signal for the issuer, indicating institutional interest and liquidity, hence a slightly above neutral score.
Positives
- A significant institutional investor, Dimensional Fund Advisors LP, holds a 5.0% stake, potentially indicating institutional confidence in Elanco Animal Health Inc.
Future Outlook
The filing does not provide any forward-looking statements or guidance regarding Elanco Animal Health Inc's future performance or operations.
Industry Context
This filing indicates a significant passive investment by a major institutional asset manager in the animal health sector. Such disclosures are common for large-cap companies and reflect routine portfolio management by institutional investors.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, potentially influencing market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of event which requires filing of this statement |
| 01/21/2026 | Filing date of the Schedule 13G statement |
Keywords
Elanco Animal Health Inc, Dimensional Fund Advisors, ELAN, Schedule 13G, Institutional Ownership, Common Stock, Investment Adviser, Animal Health
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.